Literature DB >> 12142138

Construction and deconstruction of bacterial inclusion bodies.

M M Carrió1, A Villaverde.   

Abstract

Bacterial inclusion bodies (IBs) are refractile aggregates of protease-resistant misfolded protein that often occur in recombinant bacteria upon gratuitous overexpression of cloned genes. In biotechnology, the formation of IBs represents a main obstacle for protein production since even favouring high protein yields, the in vitro recovery of functional protein from insoluble deposits depends on technically diverse and often complex re-folding procedures. On the other hand, IBs represent an exciting model to approach the in vivo analysis of protein folding and to explore aggregation dynamics. Recent findings on the molecular organisation of embodied polypeptides and on the kinetics of inclusion body formation have revealed an unexpected dynamism of these protein aggregates, from which polypeptides are steadily released in living cells to be further refolded or degraded. The close connection between in vivo protein folding, aggregation, solubilisation and proteolytic digestion offers an integrated view of the bacterial protein quality control system of which IBs might be an important component especially in recombinant bacteria.

Mesh:

Substances:

Year:  2002        PMID: 12142138     DOI: 10.1016/s0168-1656(02)00032-9

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  48 in total

1.  Restrained expression, a method to overproduce toxic membrane proteins by exploiting operator-repressor interactions.

Authors:  Anoop Narayanan; Marc Ridilla; Dinesh A Yernool
Journal:  Protein Sci       Date:  2011-01       Impact factor: 6.725

2.  Localization of chaperones DnaK and GroEL in bacterial inclusion bodies.

Authors:  M Mar Carrió; Antonio Villaverde
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

3.  Localization of functional polypeptides in bacterial inclusion bodies.

Authors:  Elena García-Fruitós; Anna Arís; Antonio Villaverde
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

4.  In vivo crystallization of human IgG in the endoplasmic reticulum of engineered Chinese hamster ovary (CHO) cells.

Authors:  Haruki Hasegawa; John Wendling; Feng He; Egor Trilisky; Riki Stevenson; Heather Franey; Francis Kinderman; Gary Li; Deirdre Murphy Piedmonte; Timothy Osslund; Min Shen; Randal R Ketchem
Journal:  J Biol Chem       Date:  2011-04-04       Impact factor: 5.157

Review 5.  Protein folding and aggregation in bacteria.

Authors:  Raimon Sabate; Natalia S de Groot; Salvador Ventura
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism.

Authors:  Guruvasuthevan R Thuduppathy; Jeffrey W Craig; Victoria Kholodenko; Arne Schon; R Blake Hill
Journal:  J Mol Biol       Date:  2006-04-06       Impact factor: 5.469

Review 7.  Functional advantages conferred by extracellular prokaryotic membrane vesicles.

Authors:  Andrew J Manning; Meta J Kuehn
Journal:  J Mol Microbiol Biotechnol       Date:  2013-04-18

8.  A novel fed-batch based cultivation method provides high cell-density and improves yield of soluble recombinant proteins in shaken cultures.

Authors:  Mirja Krause; Kaisa Ukkonen; Tatu Haataja; Maria Ruottinen; Tuomo Glumoff; Antje Neubauer; Peter Neubauer; Antti Vasala
Journal:  Microb Cell Fact       Date:  2010-02-19       Impact factor: 5.328

9.  Quality control of inclusion bodies in Escherichia coli.

Authors:  Britta Jürgen; Antje Breitenstein; Vlada Urlacher; Knut Büttner; Hongying Lin; Michael Hecker; Thomas Schweder; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-28       Impact factor: 5.328

10.  Overproduced Brucella abortus PdhS-mCherry forms soluble aggregates in Escherichia coli, partially associating with mobile foci of IbpA-YFP.

Authors:  Charles Van der Henst; Caroline Charlier; Michaël Deghelt; Johan Wouters; Jean-Yves Matroule; Jean-Jacques Letesson; Xavier De Bolle
Journal:  BMC Microbiol       Date:  2010-09-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.